377 related articles for article (PubMed ID: 29664809)
1. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
[TBL] [Abstract][Full Text] [Related]
2. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NEAT1 promotes cardiac hypertrophy through microRNA-19a-3p/SMYD2 axis.
Sun XL; Lv JL; Dou L; Chen D; Zhu YC; Hu X
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1367-1377. PubMed ID: 32096186
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
6. Shenfu Injection attenuates rat myocardial hypertrophy by up-regulating miR-19a-3p expression.
Mao ZJ; Zhang QL; Shang J; Gao T; Yuan WJ; Qin LP
Sci Rep; 2018 Mar; 8(1):4660. PubMed ID: 29549288
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
[TBL] [Abstract][Full Text] [Related]
8. The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1.
Song DW; Ryu JY; Kim JO; Kwon EJ; Kim DH
Biochem J; 2014 Jan; 457(1):151-62. PubMed ID: 24117217
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hsa-miR-19a-3p and hsa-miR-19b-3p modulation and phosphodiesterase type 5 expression in the vaginal epithelium of premenopausal women with genital arousal disorder.
Caruso G; Falzone L; Palermo G; Ricci D; Mazza G; Libra M; Caruso S; Gattuso G
J Sex Med; 2023 Jun; 20(7):935-944. PubMed ID: 37185899
[TBL] [Abstract][Full Text] [Related]
10. MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
Jia G; Liang C; Li W; Dai H
Bioengineered; 2022 Jan; 13(1):119-127. PubMed ID: 34951337
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.
Yang Y; Ago T; Zhai P; Abdellatif M; Sadoshima J
Circ Res; 2011 Feb; 108(3):305-13. PubMed ID: 21183740
[TBL] [Abstract][Full Text] [Related]
13. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
[TBL] [Abstract][Full Text] [Related]
14. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
Seok HY; Chen J; Kataoka M; Huang ZP; Ding J; Yan J; Hu X; Wang DZ
Circ Res; 2014 May; 114(10):1585-95. PubMed ID: 24657879
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
16. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
[TBL] [Abstract][Full Text] [Related]
17. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.
Li H; Xu JD; Fang XH; Zhu JN; Yang J; Pan R; Yuan SJ; Zeng N; Yang ZZ; Yang H; Wang XP; Duan JZ; Wang S; Luo JF; Wu SL; Shan ZX
Cardiovasc Res; 2020 Jun; 116(7):1323-1334. PubMed ID: 31397837
[TBL] [Abstract][Full Text] [Related]
19. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
